St. Johnís Wort

Michael Clark

Hypericum What is St. Johnís Wort?

St. Johnís Wort (Hypericum Perforatum) is a small plant with bright yellow flowers.  Wort is an old English term that means plant.  The red spots on the leaves of the plant are symbolic of the blood of St. John after his beheading.  The plant is grown worldwide but it grows especially well in parts of Northern California and Southern Oregon  (http://www.doctormurray.com/articles/worteditorial.htm).

St. Johnís Wort has not been well known in the United States until recently.  Studies on the medicine have been going on for decades in Europe.  German doctors have been prescribing it and the insurance companies have been paying for it.  It is available in many health shops in the United States and all across Europe but recently it has been selling out because of its increased popularity.  In the United States, manufacturers canít advertise it as a treatment for depression and doctors canít prescribe it because the FDA (Federal Drug Administration) wonít allow it.  It has to be advertised as a contribution to emotional balance and positive outlook or promoting a sense of balance for people with mild depression, not severe or major depression.  St. Johnís Wort comes in one of three forms: liquid, capsule, and dried form.            (http://www.vanderbilt.edu/AnS/psychology/health_psychologyStJohn.htm)

                                                                                                                                                                                                                                                                                                     What 

What is the purpose of St. Johnís Wort?

St. Johnís Wort use for depression, insomnia, and anxiety inspired a group of German doctors in the 1980ís to do research on the herb.  The findings of their studies brought the group fame in the late 1990ís.  A number of studies indicate that St. Johnís is an effective treatment for treating mild-to-moderate depression    (http://www.mothernature.com/cg/stjohns.asp).

St. Johnís is quickly becoming the most popular herbal drug in the United States.  German physicians prescribed a total of 66 million daily doses in 1994.  These German physicians now prescribe St. Johnís wort an average of 8 times more than Prozac.  These doctors claim that St. Johnís wort produces better results in relieving depression, but the medicine does not have near the amount of side effects as Prozac (http://www.doctormurray.com/articles/worteditorial.htm). 

How does St. Johnís Wort work?

            Originally, scientists thought that the reason St. Johnís worked as an antidepressant was due to a substance called hypericin.  Hypericin is antiviral and is also thought to be mood brightening.  Hypericin acts as an inhibitor of the enzyme monoamine oxidase, a bodily chemical associated with depression, thereby resulting in an increase of CNS monoamines such as serotonin and dopamine.  A new study has shown that St. Johnís Wort interacts with a link between the immune system and mood.  The immune system and the nervous system share many common biochemical features.  Changes in the serotonin, dopamine, or melatonin levels in the body may cause St. Johnís effect on the nervous system (http://www.doctormurray.com/articles/worteditorial.htm).

            Another study suggests that the antidepressant effects may result from a mixture of several pharmacologic mechanisms similar to prescription antidepressants, including monoamine oxidase inhibition, blockade of muscarinic cholinergic receptors, and inhibition of γ-aminobutyric acid (GABA), norepinephrine, dopamine, and serotonin.  Additional antidepressant activity may also occur through opposition of σ receptors in the limbic system, an area of the brain connected with regulation of emotions (Beckman, Sommi, Switzer 2000).

            There are only a few side effects in St. Johnís Wort.  The most common side effects from taking St. Johnís Wort include nausea, stomachache, lack of appetite, and tiredness.  A small amount of people who take high doses of St. Johnís Wort may experience skin reactivity to light from the sun.  Pregnant women also should not take it.  The effect that the herb has on the nervous system remains unclear and most experts recommend against taking it with some other forms of anti-depressants like Prozac or Zoloft.  Also, St. Johnís Wort greatly reduces the effectiveness of anti-HIV protease inhibitors and the organ transplant drug cyclosporin.  It should not be taken with any type of these drugs (http://www.mothernature.com/cg/stjohns.asp).  Some of the other drugs that St. Johnís should not be taken with are Indinavir, Warfarin, Oral contraceptives, Digoxin, and Theophylline (Mehta 2000).

There are many potentially serious drug interactions between St. Johnís Wort and several other prescription medicines.  Many of these interactions are the result of induction by St. Johnís Wort of various drug-metabolizing enzymes including the cytochrome P450 system and possible also P-glycoprotein.  This could result in decreased blood levels and therapeutic effect of medicines metabolized by these enzymes (Mehta 2000). 

            St. Johnís Wort affects the neurotransmitters in the brain.  This might result in drug interactions between St. Johnís Wort and certain psychotropic medicines including the selective serotonin reuptake inhibitors (SSRIs).  St. Johnís Wort may also interact dangerously with drugs used to treat migraines (sumatriptan, rizatriptan, etc.).  Elderly patients are more susceptible to the serotonin syndrome and may develop a more serious reaction (Mehta 2000).

What claims are made about the effectiveness of St. Johnís Wort?

          It is said that St. Johnís Wort is more effective than a placebo for treating mild to moderately severe depression.  This evidence comes from an analysis of all studies in which a depressed person was randomly given either a placebo or St. Johnís Wort.  According to Michael T. Murray:

 ďThere have been over 25 double-blind studies with St. Johnís wort extract in the treatment of depression.  The methodological quality of this research, particularly the studies since 1989, has been judged as being acceptable by strict criteria.  The overall results have also been judged as providing good documentation of antidepressant activityĒ (http://www.doctormurray.com/articles/worteditorial.htm).

What evidence is offered in support of St. Johnís Wort?

          At least one out of every 20 Americans gets depressed each year.  They rely on anti-depressants to help them deal with their depression.  A new study shows that St. Johnís is just as effective with fewer side effects.  In the August 3, 1996 issue of the British Medical Journal it contains 23 studies that suggests St. Johnís Wort is just as helpful as commonly used anti-depressants.  In these 23 studies, there were one thousand seven hundred and fifty-seven outpatients with mild or moderately severe depression.  Fifteen of the studies were placebo controlled and eight of them compared St. Johnís Wort with another drug treatment.  The treatment and observation period in all the studies were from periods of four to eight weeks.  The trials were performed by psychiatrists (9 of the trials), internists (7 trials), general practitioners (6 trials), and obstetricians (1 trial).  Twenty of the trials were double blind, one was single blind, and two were open (Linde, Ramirez, Mulrow, Pauls, Weidenhammer, and Melchart, 1996). 

St. Johnís Wort extracts were considerably greater to placebo (ratio = 2.67; 95% confidence interval 1.78 to 4.01) and likewise effective in standard antidepressants (single preparations 1.10; 0.93 to 1.31, combinations 1.52; 0.78 to 2.94).  There were only two dropouts for side effects with St. Johnís and seven with standard antidepressant drugs.  Side effects occurred in 50 patients on St. Johnís and 84 patients on standard antidepressants (Linde et al, 1996).

There is a sufficient amount of evidence from this trial to prove that St. Johnís Wort is more effective than a placebo for treatment of depressive disorders, but it is not known whether it is more effective for certain types of disorders than others.  The current evidence is inadequate to establish whether St. Johnís is as effective as other antidepressants and if it has fewer side effects.  Additional studies should be done to compare St. Johnís Wort with other antidepressants in a well-defined group of patients.  The studies were laid out the following way (Linda et al, 1996). 

Trial

# Of patients

Diagnoses

Compared Treatment

Total hypercin/

Day (mg)

Extract/day

In (mg)

Duration of

Treatment

Halama 1991

50

Neurotic depression, adjustment disorder

Placebo

1.08

900

4

Hansgen 1994

72

Major Depression

Placebo

2.7

900

4

Hubner 1994

40

Neurotic depression, adjustment disorder

Placebo

2.7

900

4

Lehrl 1993

50

Neurotic depression, adjustment disorder

Placebo

1.08

900

4

Harrer 1994

102

Single moderately severe depressive episode

Maprotiline 75 mg

2.7

900

4

Vorback 1994

135

Major depression

Neurotic depression

Imipramine

75 mg

2.7

900

6

Werth 1989

30

Reactive depression after informing patients of necessity of amputation

Imipramine

50mg

.75

500

2

 

 

 

 

 

 

 

 

 

 

 

 

Another study on the effect of St. Johnís Wort takes 263 moderately depressed people and distributes them St. Johnís Wort, Imipramine (another anti-depressant), and a placebo.  The patients took three capsules a day of one of the three pills that were all made to taste and look the same.  After eight weeks of the experiment, the doctors distributed a survey, which is meant to measure the degree of the patientís depression.  St. Johnís Wort eased depressive symptoms significantly more than the placebo and about the same as the Imipramine.  Both drugs improved the patientís score on the survey that gauged the quality of life.  According to the researchers of the experiment, ďSt. Johnís Wort extract may thus be considered as an alternative first choice treatment in most cases of mild to moderate depression without psychotic symptoms (http://webmd.lycos.com/content/article/1728.53357).

            There are major studies that are set to begin in the fall of 2000.  McLean Depression & Anxiety Disorders Outpatient Service will do one of the studies in which it will conduct a double blind and placebo controlled trial of AlterraTM, a new extended release form of St. Johnís Wort, in 80 depressed outpatients.  Another significant study, sponsored by the National Institute of Mental Health will be a three-year, 4.3 million-dollar study.  This study will compare St. Johnís Wort to Zoloft and a placebo.  Three hundred and thirty-six patients will be selected from across the country to participate.

(http://www.selfgrowth.com/articles/ewing.html).

Who is presenting this information and why?

          There are several different people that are presenting information about St. Johnís Wort.  Naturally, online herbal shops are presenting the information in order to sell it.  But there are also web pages of people who were in depression but St. Johnís Wort helped them work through it.  There were many news articles about the herb, the safety of it, effectiveness it has in depressed patients.  The medical journals presented a lot of studies done to show the effectiveness of St. Johnís Wort.   

Summary

            According to David Menkes, ďHypericum extracts are effective in mild to moderate depression and may also be effective in severe depression if titration about the usual dose is allowed.Ē  The main advantage of people taking it is their tolerability.  Side effects are considerably mild and there is no sexual dysfunction like many other anti-depressant drugs (Menke 2000).

Based on all the evidence that I gathered.  St. Johnís Wort seems to be a good alternative anti-depressant medication.  It seems to work best on those patients that are mild to moderately depressed.  Its effectiveness on those patients with severe depression is yet to be determined.   


Works Cited

Beckman, S., Sommi, R., Switzer, J.  (2000).  Consumer Use of St. Johnís Wort: A Survey on Effectiveness, Safety, and Tolerability.  Pharmacotherapy, 20, 568-574.

Linde, K., Ramirez, G., et al. (1996). St John's wort for depression---an overview and meta-analysis of randomised clinical trials. British Medical Journal, 313, 253-258.

Mehta, Ushma. (2000).  Potentially Serious Drug Interactions Between St. Johnís Wort And Other Medicines.  South African Medical Journal, 90, 698.

Menke, David B. (2000).  The Herbalist Will See You Now.  British Medical Journal   320, 1142.

 

 

 

Psychology Department

The Health Psychology Home Page is produced and maintained by David Schlundt, PhD.
  


Vanderbilt Homepage | Introduction to Vanderbilt | Admissions | Colleges & Schools | Research Centers | News & Media Information | People at Vanderbilt | Libraries | Administrative Departments | Medical 

  Return to the Health Psychology Home Page
  Send E-mail comments or questions to Dr. Schlundt

Search

Search: Vanderbilt University
the Internet

  Help  Advanced

Tip: You can refine your last query by searching only the results by clicking on the tab above the search box

Having Trouble Reading this Page?  Download Microsoft Internet Explorer.